AI helps doctors cut risky drugs for seniors
NCT ID NCT06660979
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed trial tested a computer program that learns which reminders work best for each doctor to help them reduce high-risk medications in older patients. The study involved 70 primary care providers and over 1,200 patients aged 65 and older. The program personalized electronic health record tools to encourage deprescribing, aiming to lower the use of potentially harmful drugs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
reinforcement learning program
What this could lead to
If successful, this approach could help doctors safely reduce risky medications in older adults, potentially lowering side effects and improving health.
What could go wrong
This is a completed trial with 70 doctors, but results may not apply to other healthcare systems. The effect on patient health outcomes is not directly measured.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atrius Health
Boston, Massachusetts, 02215, United States